EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Carbon Dot-Enhanced Doxorubicin Liposomes: A Dual-Functional Nanoplatform for Cancer Therapy

Corina-Lenuta Logigan iD, Cristian Peptu iD, Corneliu S Stan, Gabriel Luta, Crina Elena Tiron iD, Mariana Pinteala iD, Aleksander Foryś iD, Bogdan Simionescu, Constanta Ibanescu iD, Adrian Tiron iD, Catalina A Peptu

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26157535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Corina-Lenuta Logigan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Natural and Synthetic Polymers, Faculty of Chemical Engineering and Environmental Protection, "Gheorghe Asachi" Technical University of…. Hauptthemen laut MEDLINE: Doxorubicin, Liposomes, Carbon, Quantum Dots. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Research, Innovation and Digitization, CNCS - UEFISCDI, Complex Projects Partnership Program CDI (PCCDI) in priority areas—PN III under UEFISCDI authority, project code PN-III-P1-1.2-PCCDI-2017-0083, Ministry of Research, Innovation and Digitization, CNCS-UEFISCDI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liposomes (LPs) represent one of the most effective nanoscale platforms for drug delivery in cancer therapy due to their favorable pharmacokinetic and various body tissue compatibility profiles. Building on recent findings showing that carbon dots derived from N-hydroxyphthalimide (CDs-NHF) possess intrinsic antitumor activity, herein, we investigate the possibility of preparing complex nano-platforms composed of LPs encapsulating CDs-NHF and/or doxorubicin (DOX) for breast and lung cancer. Various LP formulations were prepared and characterized using Cryo-TEM and Cryo-SEM for morphological analysis, while zeta potential and fluorescence assessments confirmed their stability and optical properties. Cellular effects were evaluated through immunofluorescence microscopy and proliferation assays. LPs-CDs-NHF significantly reduced cancer cell viability at lower concentrations compared to free CDs-NHF, and this effect was further amplified when combined with doxorubicin. Mechanistically, the liposomal formulations downregulated key signaling molecules including pAKT, pmTOR, and pERK, indicating the disruption of cancer-related pathways. These findings suggest that LPs containing CDs-NHF, either alone or in combination with DOX, exhibit synergistic antitumor activity and hold strong promise as multifunctional nanocarriers for future oncological applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinLiposomesCarbonQuantum DotsNeoplasmsHumansCell SurvivalCell Line, TumorCell ProliferationDrug Delivery SystemsPolyethylene Glycols

Stichwörter der Autor:innen

breast cancercarbon dots (CDs-NHF)doxorubicin synergydrug deliveryliposomeslung cancersignal transduction inhibition

Substanzen

DoxorubicinLiposomesCarbonliposomal doxorubicinPolyethylene Glycols

Autor:innen und Institutionen

  • Department of Natural and Synthetic Polymers, Faculty of Chemical Engineering and Environmental Protection, "Gheorghe Asachi" Technical University of Iasi, 700050 Iasi, Romania.
  • "Petru Poni" Institute of Macromolecular Chemistry, 700487 Iasi, Romania.
  • Regional Institute of Oncology, 700483 Iasi, Romania.
  • Centre of Polymer and Carbon Materials of the Polish Academy of Sciences, 41-819 Zabrze, Poland.

ORCID-Profile: Corina-Lenuta Logigan, Cristian Peptu, Crina Elena Tiron, Mariana Pinteala, Aleksander Foryś, Constanta Ibanescu, Adrian Tiron

Förderung

  • Ministry of Research, Innovation and Digitization, CNCS - UEFISCDI
  • Complex Projects Partnership Program CDI (PCCDI) in priority areas—PN III under UEFISCDI authority, project code PN-III-P1-1.2-PCCDI-2017-0083
  • Ministry of Research, Innovation and Digitization, CNCS-UEFISCDI

Zitieren

APA

Logigan, C. L., Peptu, C., Stan, C. S., Luta, G., Tiron, C. E., Pinteala, M., Foryś, A., Simionescu, B., Ibanescu, C., Tiron, A., & Peptu, C. A. (2025). Carbon Dot-Enhanced Doxorubicin Liposomes: A Dual-Functional Nanoplatform for Cancer Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157535

Vancouver

Logigan CL, Peptu C, Stan CS, Luta G, Tiron CE, Pinteala M, et al. Carbon Dot-Enhanced Doxorubicin Liposomes: A Dual-Functional Nanoplatform for Cancer Therapy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157535

BibTeX
@article{Logigan2025,
  author = {Logigan, Corina-Lenuta and Peptu, Cristian and Stan, Corneliu S and Luta, Gabriel and Tiron, Crina Elena and Pinteala, Mariana and Foryś, Aleksander and Simionescu, Bogdan and Ibanescu, Constanta and Tiron, Adrian and Peptu, Catalina A},
  title = {Carbon Dot-Enhanced Doxorubicin Liposomes: A Dual-Functional Nanoplatform for Cancer Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26157535}
}
Kostenlos starten →